Document is current
Any future updates will be listed below
-
Authors
,
Terrault, Norah A.
,
Castro-Narro, Graciela
,
Krag, Aleksander
,
Shiina, Shuichiro
- License Information
-
More Information
Article History
Received: 20 September 2023
Accepted: 20 September 2023
First Online: 27 September 2023
Declarations
:
: Norah A. Terrault consults for Moderna. She received institutional grants from GSK, Genentech-Roche, Helio Health, Gilead, and Durect. She has other interests in CCO and Simply Speaking. AK has served as speaker for Novo Nordisk, Norgine, Siemens, and Nordic Bioscience, and participated in advisory boards for Norgine, Siemens, Resalis Therapeutics, Boehringer Ingelheim, and Novo Nordisk, all outside the submitted work. Research support; Norgine, Siemens, Nordic Bioscience, Astra, Echosense. Consulting Takeda, Resalis Therapeutics, Zealand Pharma, Novo Nordisk, and Boehringer Ingelheim. Board member and co-founder Evido. Please refer to the accompanying ICMJE disclosure forms for further details.
Free to read: This content has been made available to all.
